Ftse Mib
35.378,35
0,72%
DAX
20.454,39
0,95%
S&P 500
5.842,91
0,11%
NASDAQ
19.044,39
-0,23%
Bitcoin
96.594,78
0,09%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Celldex Therapeutics Inc (CLDX) Celldex Therapeutics Inc (CLDX) Notizie

Celldex Therapeutics Inc

CLDX
22,94
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 12:25:33
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202414:01GLOBECelldex Initiates Phase 2 Study of Barzolvolimab in Atopic..
20/11/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202414:01GLOBECelldex Announces First Patient Dosed in Phase 1 Healthy..
15/11/202401:47EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202418:18EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202412:12EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202400:00EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/11/202422:01GLOBECelldex Therapeutics to Present at Upcoming Investor..
08/11/202416:52EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:01EDGAR2Form 8-K - Current report
26/10/202423:43GLOBECelldex Announces Barzolvolimab Met All Primary and..
25/10/202414:01GLOBECelldex Announces Upcoming Late Breaking Oral Presentation..
25/9/202416:45GLOBECelldex Therapeutics Presents Landmark 52 Week Results from..
16/9/202414:01GLOBECelldex Announces Upcoming Late Breaking Oral Presentation..
12/9/202422:01GLOBECelldex Therapeutics to Present at Upcoming Investor..
08/8/202422:01EDGAR2Form 8-K - Current report
08/8/202422:01GLOBECelldex Reports Second Quarter 2024 Financial Results and..
29/7/202422:01GLOBECelldex Therapeutics Presents Positive Topline Results from..
16/7/202414:01GLOBECelldex Therapeutics Initiates Global Phase 3 Program for..
18/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:34EDGAR2Form 144 - Report of proposed sale of securities
14/6/202423:12EDGAR2Form 144 - Report of proposed sale of securities
14/6/202422:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/6/202414:00EDGAR2Form 8-K - Current report
13/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:23EDGAR2Form 144 - Report of proposed sale of securities
07/6/202422:57EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 22,94

La tua Cronologia

NASDAQ
CLDX
Celldex Therapeutics
TG
8JI
i80 Gold
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network